US FDA Never Fully Enforced The Clozapine REMS. Now’s It’s Not Needed

 
• By Sue Sutter
  
Dominoes falling
A patient advocacy group said the elimination of the REMS is the first domino to fall in improving clozapine access. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Geography